CHI3L1 and CHI3L2 overexpression in motor cortex and spinal cord of sALS patients

Molecular and Cellular Neuroscience

Volumn 85, Issue , 2017, Pages 162-169

  Sanfilippo, C ^a   Longo, A ^a   Lazzara, F ^a   Cambria, D ^a   Distefano, G ^a   Palumbo, M ^a   Cantarella, A ^a   Malaguarnera, L ^a   Di Rosa, M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

C1s; CHI3L1; CHI3L2; Motor cortex; sALS; SERPINA3

Indexed keywords

CHITINASE 3 LIKE PROTEIN 1; CHITINASE 3 LIKE PROTEIN 2; COMPLEMENT COMPONENT C1S; GLYCOSIDASE; HLA DQA1 ANTIGEN; UNCLASSIFIED DRUG; CHI3L1 PROTEIN, HUMAN; CHI3L2 PROTEIN, HUMAN; CHITINASE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN BIOPSY; C1S GENE; CONTROLLED STUDY; GENE; HLA DQA1 GENE; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; MOTOR CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RRAD GENE; SERPINA3 GENE; SMOKING; SPINAL CORD; SPINAL CORD BIOPSY; SURVIVAL TIME; UPREGULATION; BIOSYNTHESIS; METABOLISM; NERVE DEGENERATION;

AMYOTROPHIC LATERAL SCLEROSIS; CHITINASE-3-LIKE PROTEIN 1; CHITINASES; HUMANS; MOTOR CORTEX; NERVE DEGENERATION; SPINAL CORD; UP-REGULATION;

EID: 85031042184     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2017.10.001     Document Type: Article

References (67)

1. Anand, A., Gupta, P.K., Prabhakar, S., Sharma, S., Thakur, K., Analysis of smoking and LPO in ALS. Neurochem. Int. 71 (2014), 47–55.
2. Areshkov, P.O., Avdieiev, S.S., Balynska, O.V., Leroith, D., Kavsan, V.M., Two closely related human members of the chitinase-like family, CHI3L1 and CHI3L2, activate ERK1/2 in 293 and U373 cells but have the different influence on cell proliferation. Int. J. Biol. Sci. 8 (2012), 39–48.
3. Arion, D., Unger, T., Lewis, D.A., Levitt, P., Mirnics, K., Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol. Psychiatry 62 (2007), 711–721.
4. Aronica, E., Baas, F., Iyer, A., ten Asbroek, A.L., Morello, G., Cavallaro, S., Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol. Dis. 74 (2015), 359–376.
5. Baker, C., Belbin, O., Kalsheker, N., Morgan, K., SERPINA3 (aka alpha-1-antichymotrypsin). Front. Biosci. 12 (2007), 2821–2835.
6. Balendra, R., Patani, R., Quo vadis motor neuron disease?. World J. Methodol. 6 (2016), 56–64.
7. Barbeito, L.H., Pehar, M., Cassina, P., Vargas, M.R., Peluffo, H., Viera, L., Estevez, A.G., Beckman, J.S., A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. Brain Res. Rev. 47 (2004), 263–274.
8. Bleau, G., Massicotte, F., Merlen, Y., Boisvert, C., Mammalian chitinase-like proteins. EXS 87 (1999), 211–221.
9. Bonneh-Barkay, D., Bissel, S.J., Wang, G., Fish, K.N., Nicholl, G.C., Darko, S.W., Medina-Flores, R., Murphey-Corb, M., Rajakumar, P.A., Nyaundi, J., Mellors, J.W., Bowser, R., Wiley, C.A., YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am. J. Pathol. 173 (2008), 130–143.
10. Bonneh-Barkay, D., Wang, G., Starkey, A., Hamilton, R.L., Wiley, C.A., In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J. Neuroinflammation, 7, 2010, 34.
11. Bonneh-Barkay, D., Bissel, S.J., Kofler, J., Starkey, A., Wang, G., Wiley, C.A., Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation. Brain Pathol. 22 (2012), 530–546.
12. Burman, J., Raininko, R., Blennow, K., Zetterberg, H., Axelsson, M., Malmestrom, C., YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis. J. Neuroimmunol. 292 (2016), 52–57.
13. Dangond, F., Hwang, D., Camelo, S., Pasinelli, P., Frosch, M.P., Stephanopoulos, G., Stephanopoulos, G., Brown, R.H. Jr., Gullans, S.R., Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol. Genomics 16 (2004), 229–239.
14. Di Rosa, M., Malaguarnera, L., Genetic variants in candidate genes influencing NAFLD progression. J. Mol. Med. 90 (2012), 105–118.
15. Di Rosa, M., Zambito, A.M., Marsullo, A.R., Li Volti, G., Malaguarnera, L., Prolactin induces chitotriosidase expression in human macrophages through PTK, PI3-K, and MAPK pathways. J. Cell. Biochem. 107 (2009), 881–889.
16. Di Rosa, M., Malaguarnera, G., De Gregorio, C., D'Amico, F., Mazzarino, M.C., Malaguarnera, L., Modulation of chitotriosidase during macrophage differentiation. Cell Biochem. Biophys. 66 (2013), 239–247.
17. Di Rosa, M., Malaguarnera, G., De Gregorio, C., Drago, F., Malaguarnera, L., Evaluation of CHI3L-1 and CHIT-1 expression in differentiated and polarized macrophages. Inflammation 36 (2013), 482–492.
18. Di Rosa, M., Sanfilippo, C., Libra, M., Musumeci, G., Malaguarnera, L., Different pediatric brain tumors are associated with different gene expression profiling. Acta Histochem. 117 (2015), 477–485.
19. Di Rosa, M., Distefano, G., Zorena, K., Malaguarnera, L., Chitinases and immunity: ancestral molecules with new functions. Immunobiology 221 (2016), 399–411.
20. Durrenberger, P.F., Fernando, F.S., Magliozzi, R., Kashefi, S.N., Bonnert, T.P., Ferrer, I., Seilhean, D., Nait-Oumesmar, B., Schmitt, A., Gebicke-Haerter, P.J., Falkai, P., Grunblatt, E., Palkovits, M., Parchi, P., Capellari, S., Arzberger, T., Kretzschmar, H., Roncaroli, F., Dexter, D.T., Reynolds, R., Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study. Acta Neuropathol. 124 (2012), 893–903.
21. Durrenberger, P.F., Fernando, F.S., Kashefi, S.N., Bonnert, T.P., Seilhean, D., Nait-Oumesmar, B., Schmitt, A., Gebicke-Haerter, P.J., Falkai, P., Grunblatt, E., Palkovits, M., Arzberger, T., Kretzschmar, H., Dexter, D.T., Reynolds, R., Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study. J. Neural Transm. 122 (2015), 1055–1068.
22. Fernandez, O., Alvarez-Cermeno, J.C., Arnal-Garcia, C., Arroyo-Gonzalez, R., Brieva, L., Calles-Hernandez, M.C., Casanova-Estruch, B., Comabella, M., Garcia-Merino, J.A., Izquierdo, G., Meca-Lallana, J., Mendibe-Bilbao Mdel, M., Munoz-Garcia, D., Olascoaga, J., Oliva-Nacarino, P., Oreja-Guevara, C., Prieto, J., Ramio-Torrenta, L., Romero-Pinel, L., Saiz, A., Rodriguez-Antiguedad, A., Grupo Post, E., Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III). Rev. Neurol. 59 (2014), 371–379.
23. Fusetti, F., Pijning, T., Kalk, K.H., Bos, E., Dijkstra, B.W., Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39. J. Biol. Chem. 278 (2003), 37753–37760.
24. Greene, C.S., Krishnan, A., Wong, A.K., Ricciotti, E., Zelaya, R.A., Himmelstein, D.S., Zhang, R., Hartmann, B.M., Zaslavsky, E., Sealfon, S.C., Chasman, D.I., FitzGerald, G.A., Dolinski, K., Grosser, T., Troyanskaya, O.G., Understanding multicellular function and disease with human tissue-specific networks. Nat. Genet. 47 (2015), 569–576.
25. Hinsinger, G., Galeotti, N., Nabholz, N., Urbach, S., Rigau, V., Demattei, C., Lehmann, S., Camu, W., Labauge, P., Castelnovo, G., Brassat, D., Loussouarn, D., Salou, M., Laplaud, D., Casez, O., Bockaert, J., Marin, P., Thouvenot, E., Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis. Mult. Scler. 21 (2015), 1251–1261.
26. Horvath, S., Mirnics, K., Immune system disturbances in schizophrenia. Biol. Psychiatry 75 (2014), 316–323.
27. Hu, B., Trinh, K., Figueira, W.F., Price, P.A., Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J. Biol. Chem. 271 (1996), 19415–19420.
28. Huang, C., Huang, B., Bi, F., Yan, L.H., Tong, J., Huang, J., Xia, X.G., Zhou, H., Profiling the genes affected by pathogenic TDP-43 in astrocytes. J. Neurochem. 129 (2014), 932–939.
29. Hussain, M., Wilson, J.B., New paralogues and revised time line in the expansion of the vertebrate GH18 family. J. Mol. Evol. 76 (2013), 240–260.
30. Kalsheker, N.A., Alpha 1-antichymotrypsin. Int. J. Biochem. Cell Biol. 28 (1996), 961–964.
31. Kester, M.I., Teunissen, C.E., Sutphen, C., Herries, E.M., Ladenson, J.H., Xiong, C., Scheltens, P., van der Flier, W.M., Morris, J.C., Holtzman, D.M., Fagan, A.M., Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort. Alzheimers Res. Ther., 7, 2015, 59.
32. Kiernan, M.C., Vucic, S., Cheah, B.C., Turner, M.R., Eisen, A., Hardiman, O., Burrell, J.R., Zoing, M.C., Amyotrophic lateral sclerosis. Lancet 377 (2011), 942–955.
33. Kolson, D.L., YKL-40: a candidate biomarker for simian immunodeficiency virus and human immunodeficiency virus encephalitis?. Am. J. Pathol. 173 (2008), 25–29.
34. Komine, O., Yamanaka, K., Neuroinflammation in motor neuron disease. Nagoya J. Med. Sci. 77 (2015), 537–549.
35. Lee, C.G., Da Silva, C.A., Lee, J.Y., Hartl, D., Elias, J.A., Chitin regulation of immune responses: an old molecule with new roles. Curr. Opin. Immunol. 20 (2008), 684–689.
36. Libreros, S., Iragavarapu-Charyulu, V., YKL-40/CHI3L1 drives inflammation on the road of tumor progression. J. Leukoc. Biol. 98 (2015), 931–936.
37. Libreros, S., Garcia-Areas, R., Shibata, Y., Carrio, R., Torroella-Kouri, M., Iragavarapu-Charyulu, V., Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model. Int. J. Cancer 131 (2012), 377–386.
38. Mollgaard, M., Degn, M., Sellebjerg, F., Frederiksen, J.L., Modvig, S., Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis. Eur. J. Neurol. 23 (2016), 898–905.
39. Nezgovorova, V., Liu, Q., Hu, B., Villalobos, J.L., Yan, X., Niu, N., Holm, C., Grant, N.P., Marone, S., Ravage-Mass, L., Lee, C.G., Elias, J.A., Cohn, L., Chupp, G.L., Sputum gene expression of IL-13 receptor alpha2 chain correlates with airflow obstruction and helper T-cell type 2 inflammation in asthma. Ann. Am. Thorac. Soc. 13:Suppl. 1 (2016), S96–97.
40. Novakova, L., Axelsson, M., Khademi, M., Zetterberg, H., Blennow, K., Malmestrom, C., Piehl, F., Olsson, T., Lycke, J., Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis. Mult. Scler. 23:1 (2016), 62–71.
41. Keifer, O.P. Jr., O'Connor, D.M., Boulis, N.M., Gene and protein therapies utilizing VEGF for ALS. Pharmacol. Ther. 141 (2014), 261–271.
42. Ohno, M., Bauer, P.O., Kida, Y., Sakaguchi, M., Sugahara, Y., Oyama, F., Quantitative real-time PCR analysis of YKL-40 and its comparison with mammalian chitinase mRNAs in normal human tissues using a single standard DNA. Int. J. Mol. Sci. 16 (2015), 9922–9935.
43. Otsuka, K., Matsumoto, H., Niimi, A., Muro, S., Ito, I., Takeda, T., Terada, K., Yamaguchi, M., Matsuoka, H., Jinnai, M., Oguma, T., Nakaji, H., Inoue, H., Tajiri, T., Iwata, T., Chin, K., Mishima, M., Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease. Respiration 83 (2012), 507–519.
44. Padmanabhan, J., Levy, M., Dickson, D.W., Potter, H., Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Brain J. Neurol. 129 (2006), 3020–3034.
45. Pagliardini, V., Pagliardini, S., Corrado, L., Lucenti, A., Panigati, L., Bersano, E., Servo, S., Cantello, R., D'Alfonso, S., Mazzini, L., Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. J. Neurol. Sci. 348 (2015), 245–250.
46. Philips, T., Robberecht, W., Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 10 (2011), 253–263.
47. Rung, J., Brazma, A., Reuse of public genome-wide gene expression data. Nat. Rev. Genet. 14 (2013), 89–99.
48. Saidi, A., Javerzat, S., Bellahcene, A., De Vos, J., Bello, L., Castronovo, V., Deprez, M., Loiseau, H., Bikfalvi, A., Hagedorn, M., Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Int. J. Cancer 122 (2008), 2187–2198.
49. Sakazaki, Y., Hoshino, T., Takei, S., Sawada, M., Oda, H., Takenaka, S., Imaoka, H., Matsunaga, K., Ota, T., Abe, Y., Miki, I., Fujimoto, K., Kawayama, T., Kato, S., Aizawa, H., Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD. PLoS One, 6, 2011, e24177.
50. Sanfilippo, C., Malaguarnera, L., Di Rosa, M., Chitinase expression in Alzheimer's disease and non-demented brains regions. J. Neurol. Sci. 369 (2016), 242–249.
51. Sanfilippo, C., Nunnari, G., Calcagno, A., Malaguarnera, L., Blennow, K., Zetterberg, H., Di Rosa, M., The chitinases expression is related to Simian Immunodeficiency Virus Encephalitis (SIVE) and in HIV encephalitis (HIVE). Virus Res. 227 (2017), 220–230.
52. Saris, C.G., Groen, E.J., Koekkoek, J.A., Veldink, J.H., van den Berg, L.H., Meta-analysis of gene expression profiling in amyotrophic lateral sclerosis: a comparison between transgenic mouse models and human patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 14 (2013), 177–189.
53. Sekine, T., Masuko-Hongo, K., Matsui, T., Asahara, H., Takigawa, M., Nishioka, K., Kato, T., Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann. Rheum. Dis. 60 (2001), 49–54.
54. Staats, K.A., Van Den Bosch, L., Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival. J. Biol. Phys. 35 (2009), 337–346.
55. Tang, H., Sun, Y., Shi, Z., Huang, H., Fang, Z., Chen, J., Xiu, Q., Li, B., YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-kappaB pathways, causing bronchial smooth muscle proliferation and migration. J. Immunol. 190 (2013), 438–446.
56. Tsuruha, J., Masuko-Hongo, K., Kato, T., Sakata, M., Nakamura, H., Sekine, T., Takigawa, M., Nishioka, K., Autoimmunity against YKL-39, a human cartilage derived protein, in patients with osteoarthritis. J. Rheumatol. 29 (2002), 1459–1466.
57. 11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 15 (2004), 601–609.
58. Uysal, S., Meric Yilmaz, F., Bogdaycioglu, N., Mungan Ozturk, S., Ak, F., Increased serum levels of some inflammatory markers in patients with multiple sclerosis. Minerva Med. 105 (2014), 229–235.
59. Valavanis, A., Schwarz, U., Baumann, C.R., Weller, M., Linnebank, M., Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations. J. Neurol. 261 (2014), 732–737.
60. Van Kirk, C.A., VanGuilder, H.D., Young, M., Farley, J.A., Sonntag, W.E., Freeman, W.M., Age-related alterations in retinal neurovascular and inflammatory transcripts. Mol. Vis. 17 (2011), 1261–1274.
61. Vega, I.E., EFhd2, a protein linked to Alzheimer's disease and other neurological disorders. Front. Neurosci., 10, 2016, 150.
62. Walker, D.G., Dalsing-Hernandez, J.E., Lue, L.F., Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease. Microvasc. Res. 75 (2008), 411–419.
63. Wang, X.W., Cai, C.L., Xu, J.M., Jin, H., Xu, Z.Y., Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis. Tumour Biol. 36 (2015), 901–907.
64. Wiley, C.A., Bissel, S.J., Murdoch, G.H., Role of CHI3L1 in neuroinflammation. Clin. Immunol., 161, 2015, 354.
65. Wong, E., Cuervo, A.M., Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 13 (2010), 805–811.
66. Yamadera, M., Fujimura, H., Inoue, K., Toyooka, K., Mori, C., Hirano, H., Sakoda, S., Microvascular disturbance with decreased pericyte coverage is prominent in the ventral horn of patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 16 (2015), 393–401.
67. Zhang, J.P., Yuan, H.X., Kong, W.T., Liu, Y., Lin, Z.M., Wangs, W.P., Guo, J.M., Increased expression of chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma. Tumour Biol. 35 (2014), 12131–12137.